UPMC backs cancer diagnostics startup Cernostics

MedCity News- The molecular technology being developed to spot cancer may be less iconic than the old image of pathologists bent over a microscope looking at tiny cells trapped between glass slides. But algorithms and cells have spurred a market teeming with venture capital and startup labs.

Read full story.